What are the responsibilities and job description for the Biotech / Life Science Recruiter (Contract to FTE) position at Genesis Therapeutics?
Genesis Therapeutics is looking for an exceptional TA Contract-to-FTE Recruiter to join our Talent Acquisition team. The Recruiter will support our Scientific divisions (currently Biology / Chemistry / Non-Clinical Development including DMPK), Clinical R&D and some other G&A areas as needed. This role requires strategic sourcing, stakeholder collaboration, and an unwavering commitment to delivering an exceptional candidate experience. As an expert in your craft, you will influence talent decisions based on data insights and market intelligence.
What you will do :
- Responsible for full cycle recruiting including sourcing, screening, selecting, assessing, closing, etc.
- Serve as an internal advisor to hiring managers to deeply understand business strategies and talent needs for today and the future
- Build a trusted advisor relationship with hiring managers through coaching and influencing on an effective search, assessment strategies, closing candidates, etc.
- Develop and execute end to end proactive sourcing strategies to ensure a diverse pipeline of candidates
- Ensure a seamless and engaging experience for candidates through all stages of the hiring process
- Partner with hiring managers to understand the specific needs of the role and tailor recruiting strategies to find the best candidates
- Stay updated on industry trends, emerging technologies and market dynamics to offer guidance to hiring managers
- Ability to bring creativity to the recruiting process to attract a diverse candidate pool
- Track, analyze, and report recruitment metrics to optimize processes and meet hiring goals
- Maintain adherence to employment laws and company policies during all recruitment activities
What you bring (Requirements) :
Genesis Therapeutics is unifying AI and biotech to discover novel and breakthrough treatments for patients with severe and devastating conditions. Genesis was founded on groundbreaking molecular ML research and since has established itself as the industry leader in AI for small molecule drug discovery. Our team of accomplished biotech leaders and expert drug hunters joins forces with deep learning researchers and software engineers who are pioneering predictive and generative AI technologies for molecules.
Our team has created the industry's most advanced molecular AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery and to enable the discovery of novel first-in-class and best-in-class small molecule drugs for challenging and / or undruggable targets.
The company has leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, Genesis has three AI platform collaborations across a range of therapeutic areas, with Gilead Sciences, Eli Lilly, and Genentech.
We raised a $200M series B in August 2023, and have raised over $300M in funding from top technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA's VC arm), BlackRock, and Menlo Ventures.
Genesis is headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego. We are proud to be an inclusive workplace and an Equal Opportunity Employer.
